Form 4: Galecto CEO Buys Shares
Insider Transaction (Form 4)
Jennifer Jarrett, Director, President and CEO and a Director of Galecto, Inc., purchased 12,500 shares of common stock on September 25, 2026 for $20.23 per share.
Summary
- Open-market purchase: acquired 12,500 Ordinary Shares at $20.23 ($252,875) on September 25, 2026; holds 512,500 after (Direct).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $252,875, committing personal capital to the stock.
Insider Transactions
Jennifer Jarrett — Director, Officer (Director, President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-25 | Open-market purchase | Ordinary Shares | 12,500 | $20 | $252.9K | 512,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-25 | Open-market purchase (12,500 shares) |
Keywords
insider transaction, Form 4, DMRA, Damora Therapeutics, Inc., bullish, Jennifer Jarrett
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.